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Summary
Cell-tracing studies in the mouse indicate that the car-
diac lineage arises from a population that expresses
the vascular endothelial growth factor receptor 2
(VEGFR2, Flk-1), suggesting that it may develop from
a progenitor with vascular potential. Using the embry-
onic stem (ES) cell differentiationmodel, we have iden-
tified a cardiovascular progenitor based on the tem-
poral expression of the primitive streak (PS) marker
brachyury and Flk-1. Comparable progenitors could
also be isolated from head-fold stage embryos. When
cultured with cytokines known to function during
cardiogenesis, individual cardiovascular progenitors
generated colonies that displayed cardiomyocyte, en-
dothelial, and vascular smooth muscle (VSM) poten-
tial. Isolation and characterization of this previously
unidentified population suggests that the mammalian
cardiovascular system develops from multipotential
progenitors.
Introduction
The heart primordium is derived from mesodermal cells
that migrate through the primitive streak (PS) to the an-
terior-proximal side of the embryo where they organize
as an epithelial layer to initially form a structure known
as the cardiac crescent at approximately E7.75 of devel-
opment (Garcia-Martinez and Schoenwolf, 1993; Tam
et al., 1997). Shortly thereafter, the cardiac crescent
fuses at the midline and gives rise to the primordial heart
tube, which undergoes a process of looping and rapid
growth to generate the embryonic heart. It is now well
established that the heart develops from two separate
progenitor pools or heart fields that arise from distinct
mesodermal populations at different times (Cai et al.,
2003; Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo
et al., 2001; Zaffran et al., 2004). The first population to
migrate to the heart region originates from the anterior
splanchnic mesoderm and establishes the primary heart
field that gives rise to the early heart tube and ultimately
contributes to the left ventricle and atria (Dehaan, 1963;
Zaffran et al., 2004). The second cardiogenic population
of the embryo is derived from pharyngeal mesoderm
(Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al.,
2001; Zaffran et al., 2004). These cells constitute the sec-
ondary or anterior heart field and contribute initially to the
arterial end of the developing heart tube at E9.5 and sub-
sequently to the right ventricle and outflow tract of the
*Correspondence: gordon.keller@mssm.edumature heart (Kelly et al., 2001; Zaffran et al., 2004).
Retrospective clonal analyses have shown that the two
heart fields are established as distinct lineages early in
development and likely segregate from a common pro-
genitor at the time of gastrulation (Meilhac et al., 2004).
Molecular studies have uncovered a number of differ-
ent key transcription factors that are expressed in and
function at specific stages of myocardial development
and heart formation. Two of the earliest markers of the
cardiac lineage, Mesp1 and Mesp2, are expressed tran-
siently in the PS populations that contribute to both heart
fields (Kitajima et al., 2000; Saga et al., 1999). Both genes
are required for proper movement of the cells to the an-
terior region of the embryo (Kitajima et al., 2000). In the
anterior region, cells of the cardiac crescent are exposed
to cytokines of the BMP (Schultheiss et al., 1997) and
FGF (Reifers et al., 2000) families as well as to inhibitors
of the Wnt pathway (Marvin et al., 2001; Schneider and
Mercola, 2001; Tzahor and Lassar, 2001), resulting in
the onset of cardiac differentiation marked by expres-
sion of two key regulators of the lineage, Nkx2.5 (Lints
et al., 1993) and GATA-4 (Arceci et al., 1993; Heikinheimo
et al., 1994; Kelley et al., 1993). Myocardial maturation
within the cardiac crescent is associated with expres-
sion of contractile proteins including myosin light
chain-2a, (MLC2a) (Kubalak et al., 1994) and sarco-
meric-MHC (Han et al., 1992), expressed in the cardiac
crescent and throughout the nascent heart tube. In addi-
tion to defining specific stages of cardiac development,
gene expression patterns were instrumental in establish-
ing the concept of two heart fields. Expression of the lim
domain gene Isl1 and the growth factor FGF10 distin-
guish the two populations as they are both detected
in progenitors of the secondary but not in those of the
primary heart field (Cai et al., 2003; Kelly et al., 2001).
Tbx5, a T-box transcription factor, is initially expressed
throughout the cardiac crescent and then appears to
be restricted to derivatives of the primary heart field (Bru-
neau et al., 1999, 2001; Buckingham et al., 2005; Zaffran
et al., 2004). Genes expressed uniquely in the earliest pri-
mary heart field progenitors have not been described.
While the two origins of heart progenitors are now well
demonstrated, the specification and relationship of the
earliest cardiac lineages, the myocardium and endocar-
dium, have not been elucidated. During heart develop-
ment, the cooperative interactions of these lineages
are critical for many aspects of heart morphogenesis, in-
cluding establishment of the conduction system (Carra-
way et al., 1997; Meyer and Birchmeier, 1995; Meyer
et al., 1997; Rentschler et al., 2002), trabeculation (Gass-
mann et al., 1995; Lee et al., 1995), and myocyte growth
and survival (Lavine et al., 2005; Zhao et al., 1998). In-
sights into these early stages of cardiac development
have been provided by lineage-tracing studies in the
mouse that demonstrate that the endocardium and
a population of the myocardium develop from an inter-
mediate population that expresses Flk-1 (Ema et al.,
2006; Motoike et al., 2003). This Flk-1+ population ap-
pears to develop as the cells exit the PS and begin to mi-
grate to form the cardiac crescent (Ema et al., 2006).
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dial and endothelial lineages develop from a common
Flk-1+ progenitor. Such a progenitor could represent the
cardiac equivalent of the hemangioblast of the hemato-
poietic system, a Flk-1+ progenitor that is specified at the
onset of embryonic blood cell development and displays
the potential to generate both hematopoietic and vascu-
lar progeny (Huber et al., 2004). Although the concept of
a comparable multipotential cardiovascular progenitor
is attractive and consistent with findings from lineage
tracing experiments, the identification and characteriza-
tion of such a cell has not been possible due to the small
size and inaccessibility of the early mouse embryo.
The outstanding capacity of embryonic stem (ES) cells
to generate differentiated progeny in vitro offers a pow-
erful model system for studying mammalian develop-
ment and lineage commitment as it overcomes the prob-
lems of accessibility and cell numbers associated with
working with the early embryo (Keller, 2005). The ES-
cell model was instrumental in the identification and
characterization of the hemangioblast and in providing
approaches for the isolation of a comparable progenitor
in the early embryo (Choi et al., 1998; Huber et al., 2004).
Through the use of an ES-cell line with the green fluores-
cent protein cDNA targeted to the mesodermal gene
brachyury (GFP-Bry cells), more recent studies have
demonstrated that the sequential allocation of mesoder-
mal cells to hemangioblast and cardiac fates, found dur-
ing embryonic development (Kinder et al., 1999), also
takes place in ES-cell-derived embryoid bodies (EBs)
(Fehling et al., 2003; Kouskoff et al., 2005). They showed
that within 72 hr of differentiation, the hemangioblast
and cardiac potential within the developing embryoid
bodies (EBs) segregated to distinct populations, defined
as GFP-Bry+/Flk-1+ (D3.25 Flk-1+) and GFP-Bry+/Flk-12
(D3.25 Flk-12), respectively (Kouskoff et al., 2005). These
findings established the identity of the earliest cardiac
mesoderm population, both from the perspective of
markers and the temporal pattern of development.
To further define the developmental progression of
this cardiac mesoderm, we followed the maturation
of the GFP-Bry+/Flk-12 population and demonstrated
that it generates a second Flk-1+ population that dis-
plays robust cardiac potential. Clonal assays revealed
that the second Flk-1+ population contained progenitors
with cardiomyocyte, vascular smooth muscle (VSM),
and endothelial potential. Furthermore, these clones
displayed molecular profiles consistent with cells of
the primary and secondary heart fields. Similar cardio-
vascular progenitor cells could be isolated from the
anterior side of head-fold-stage mouse embryos. To-
gether, these findings document the existence of a
Flk-1+ cardiovascular progenitor, which is distinct from
the hemangioblast, and in doing so strongly support
the concept that the mammalian cardiovascular system
develops from multipotential progenitor cells.
Results
Cardiac Potential Is Enriched in the D4.25 GFP-Bry+/
Flk-1+ Population during ES-Cell Differentiation
To identify and characterize cardiac progenitor cells
within the D3.25 Flk-12 cell population, we analyzed
its developmental progression in more detail. In theprotocol established in our earlier study, D3.25 GFP-
Bry+/Flk-12 cells were allowed to reaggregate for 24 hr
to enable the continued differentiation of the brachyury-
expressing mesodermal populations. Following 2–3
days of culture on gelatin-coated wells in serum-free
(SF) conditions, cells from these aggregates differenti-
ated into populations of contracting cardiomyocytes
(Kouskoff et al., 2005). Analysis of the GFP-Bry+/Flk-12-
derived aggregates prior to replating revealed that a sub-
population of these cells upregulated Flk-1 expression
during the 24 hr reaggregation step (Figure 1A). The
size of the Flk-1+ population varied from 5% to 10% of
the total GFP-Bry population when the cells were allowed
to aggregate in SF media in the absence of added cyto-
kines (data not shown). The proportion of Flk-1+ cells
increased to greater than 20% of the total population
if VEGF was included in the reaggregation culture.
To determine which population contained the cardio-
myocyte potential, the Flk-1+ and Flk-12 populations
were isolated from the aggregates (day 4.25 presort)
and plated onto gelatinized microtiter wells. Virtually
all cardiomyocyte potential segregated to the Flk-1+
population. Within 2–3 days of culture, the Flk-1+ popu-
lation generated discrete areas of contracting cells. Fol-
lowing an additional 2–3 days, these areas expanded,
resulting in the development of a single mass of contract-
ing cells covering the entire well (Supplemental Data and
Movie S1 available with this article online). In contrast to
the Flk-1+ population, very little cardiomyocyte develop-
ment was observed in cultures of Flk-12 cells. To quan-
tify the extent of cardiomyocyte development in each
population, the cardiac isoform of TroponinT (cTnT)
was evaluated by intracellular flow cytometry. Greater
than 50% of the cells in the D4.25 Flk-1+ cultures ex-
pressed cTnT as compared to 8% of the cells from the
D3.25 Flk-1+ population and 4% from the D3.25 Flk-12
population (Figure 1B).
The D4.25 Flk-1+ cardiac population is generated from
D3.25 Flk-12 cells following a 24 hr reaggregation step,
whereas the D3.25 Flk-1+ population that displayed little
cardiac potential was assayed directly without reaggre-
gation. One possible explanation for the difference in
cardiac potential between the D3.25 Flk-12 and D3.25
Flk-1+ populations is that one was reaggregated, while
the other was not. To determine if this is the case,
D3.25 Flk-1+ cells were reaggregated for 24 hr in the
same conditions used for the D3.25 Flk-12 population
and then replated in the monolayer assay. Very few con-
tracting cells were observed following 4 days of culture.
Flow cytometric analysis revealed the presence of very
low numbers of cTnT-positive cells, consistent with the
lack of contracting myocytes (Figure 1C). These findings
strongly suggest that the ES-cell cardiomyocyte lineage
develops from a Flk-1+ population that emerges later
than, and is distinct from, the earliest Flk-1+ population
that has hemangioplast potential and displays little car-
diac potential (Figure 1D). These populations will now
be referred to as D3.25 Flk-1+ and D4.25 Flk-1+ cells.
Emergence of the Flk-1+ Cardiac Progenitor
Population Precedes Expression of Early Cardiac
Transcription Factors
Contracting cardiomyocytes are first observed following
2 days of culture of the D4.25 Flk-1+ population,
Flk-1 Cardiovascular Progenitor Cells
725Figure 1. Development of D3.25 and D4.25
Flk-1+ Populations from Serum-Stimulated
EBs and Their Commitment to the Cardiac
Lineage
(A) GFP-Bry+/Flk-1+ and GFP-Bry+/Flk-12
populations were isolated from day 3.25
EBs by cell sorting. The GFP-Bry+/Flk-12
cells were reaggreaged in SF media supple-
mented with VEGF and bFGF for 24 hr. At
this stage (D4.25), the aggregates were dis-
persed and separated into Flk-1+ and Flk-12
fractions by cell sorting.
(B) Cells (6 3 104) from the D3.25 Flk-1+,
D3.25 Flk-12, D4.25 Flk-1+, and D4.25 Flk-12
population were plated directly into micro-
titer wells in SF conditions. Following 5 days
of culture, the cells were harvested, counted,
stained for cTnT, and analyzed by flow cyto-
metric analysis.
(C) Cells (6 3 104) from the D3.25 Flk-1+ pop-
ulation were reaggregated for 24 hr in SF
conditions followed by trypsinization and
replating onto microtiter wells. Following 5
days of culture, cells were harvested and
analyzed as in (B).
(D) Schematic of mesoderm, hemangioblast,
and cardiac formation during ES/EB differen-
tiation and embryonic development.indicating that it represents an early stage of lineage de-
velopment. To further define the developmental status
of this D4.25 Flk-1+ population with respect to the other
ES-cell populations and to the contracting myocytes, we
analyzed the expression patterns of genes known to
mark specific stages of cardiac development (Figure 2).
The PS marker Mesp1 was expressed in each of the iso-
lated GFP-Bry populations (Saga et al., 1999). Its ex-
pression declined as the D4.25 Flk-1+ population ma-
tured to form contracting cells. Isl1, a gene expressed
in progenitors giving rise to the secondary heart field
(Cai et al., 2003) as well as limbs (Yang et al., 2006), neu-
ronal subsets, and pancreatic endoderm (Karlsson et al.,
1990; Thor et al., 1991), was also detected in each of the
sorted populations, although levels tended to be higher
in the day 4 populations. Expression was readily de-
tected in the contracting cultures. GATA-4, expressed
in visceral and definitive endoderm and cardiac meso-
derm of the embryo (Arceci et al., 1993; Heikinheimo
et al., 1994; Kelley et al., 1993) was detected in all pop-
ulations analyzed. The early acting transcription factors
Nkx2.5 and Mef2c were first expressed following 1 day
of culture of the D4.25 Flk-1+ progenitors. Tbx5 as well
as Tbx20, a gene normally expressed in the endocar-
dium and myocardium of the developing heart (Stennard
et al., 2003), and Mlc2v, a gene that encodes contractile
proteins, were all detected with the onset of contraction
in the cultures. The endothelial markers Flk-1 and CD31
were expressed in all of the isolated fractions as well as
in the replated contracting populations. Together, the
findings from these analyses demonstrate that the mo-lecular progression of mesoderm to nascent cardiac tis-
sue and contracting myocytes found in the early embryo
is recapitulated in the ES-cell model. In addition, they
position the D4.25 Flk-1+ cardiac progenitor population
Figure 2. Gene Expression Profiles of Sorted GFP-Bry/Flk-1 Popu-
lations and Developing Cardiac Cultures
D3.25 Flk-1+, D3.25 Flk-12, D4.25 Flk-1+, and D4.25 Flk-12 sorted
populations and developing cardiac cultures derived from the
D4.25 Flk-1+ fraction were isolated and analyzed by PCR. The star
and bolding at D6 indicate the onset of contraction. Expression pro-
files representing endothelium (Flk-1, CD31), mesoderm (Mesp1),
and cardiac markers (Isl1, Nkx2.5, GATA4, Mef2c, Tbx5, Tbx20,
and Mlc2v) were analyzed. Controls include H2O and neonatal
mouse heart.
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and Lineage Analysis of Individual Colonies
(A) Images of a blast colony generated from
D3.25 Flk-1+ cells, a cardiac colony gener-
ated from D4.25 Flk-1+ cells, and a cardiac
colony expanded in liquid culture. Arrow indi-
cates the region of contracting cells (see Sup-
plemental Data and Movie S2).
(B) PCR analysis of individual colonies grown
for 2, 4, and 6 days in MEC cultures. Colonies
were harvested and subject to molecular
analysis at the indicated days. Lanes repre-
sent individual colonies.
(C) Immunostaining for cTNT and CD31 pro-
tein expression of cardiac colonies expanded
for 2 days in liquid culture. Two representa-
tive colonies are shown.at a developmental stage preceding the upregulation of
expression of the transcription factors Nkx2.5 and
Mef2c.
The D4.25 Flk-1+ Population Contains Cardiac
Progenitors that Display Cardiomyocyte,
Endothelial and VSM Lineage Potential
We have previously shown that the D3.25 Flk-1+ EB-
derived population has hemangioblast potential defined
by the presence of progenitors known as blast-colony-
forming cells (BL-CFCs) that display the ability to gener-
ate blast colonies consisting of the hematopoietic, vas-
cular endothelial, and VSM lineages (Choi et al., 1998;
Fehling et al., 2003; Kouskoff et al., 2005; Nishikawa
et al., 1998) (Figure 3A, blast colony). To determine if
the D4.25 Flk-1+ population contained comparable col-
ony-forming cells for the cardiac lineages, we cultured
these cells in methylcellulose (MEC) containing VEGF
and bFGF as well as cytokines known to function in early
heart formation including BMP4 (Schultheiss et al., 1997)
and the Wnt inhibitor DKK1 (Marvin et al., 2001;
Schneider and Mercola, 2001; Tzahor and Lassar,
2001) (cardiac MEC). Following 4–6 days of culture in
these conditions, the D4.25 Flk-1+ cells generated tightly
packed colonies that could easily be distinguished from
the D3.25 Flk-1+ BL-CFC-derived blast-cell colonies
(Figure 3A, cardiac colony). Between 300 and 1000 car-
diac colonies developed from 23 104 plated cells. When
6-day-old colonies were picked from the MEC and re-plated onto a gelatin substrate in SF conditions, 25%–
90% of the colonies began spontaneous contraction
(Figure 3A, contracting cardiac colony, Supplemental
Data, and Movie S2). These findings demonstrate that
progenitors within the D4.25 Flk-1+ population respond
to cytokines found in the heart field of the mouse embryo
and generate colonies that contain cardiomyocte
potential.
Molecular analysis of colonies at days 2, 4, and 6 of
growth revealed that greater than 60% expressed
Nkx2.5 and Flk-1, suggesting most have both cardiac
and endothelial potential (Figure 3B). Most colonies
from the three different days also expressed GATA4.
The overall expression patterns did change with colony
age as the 2- and 4-day-old colonies expressed readily
detectable levels of cardiac and vascular genes whereas
those isolated at day 6 of growth preferentially ex-
pressed genes indicative of cardiomyocyte maturation.
In addition to Nkx2.5, some of the day 2 colonies ex-
pressed other genes associated with cardiac develop-
ment, including MLC2a, Tbx5, and Isl1. Expression of
Isl1 in some of these colonies suggests that they may
contain progenitors of the anterior heart field. Coexpres-
sion of FGF10 in one of the Isl1+ colonies is consistent
with this interpretation. The Isl1-negative colonies may
be representative of the primary heart field as suggested
by the expression of Tbx5 in one of them. By day 4 of
growth, a larger portion of the colonies expressed
MLC-2a and Tbx5 than was found at day 2, suggesting
Flk-1 Cardiovascular Progenitor Cells
727Figure 4. Multilineage Potential of D4.25 Flk-
1+-Derived Progenitors
(A) PCR analysis of expanded colonies gener-
ated from D4.25 Flk-1+ cells. Four-day-old
colonies were picked either from bulk cul-
tures initiated in 35 mm dishes (2 3 104
cells/ml; D4.25 Flk-1+ bulk; three representa-
tive colonies are shown) or from microtiter
wells seeded with single D4.25 Flk-1+ cells
(D4.25 Flk-1+ single cell). Colonies were ex-
panded for 2 days in liquid culture prior to
analysis. Comparable aged blast colonies
generated from D3.25 Flk-1+ cultured in Blast
MEC for 4 days (D3.25 Flk-1+ Blast) were also
analyzed. Controls include H2O, neonatal
heart, and skeletal-muscle cDNA.
(B) Relationship between the number of car-
diac colonies and the number of D4.25 Flk-
1+ cells plated. D4.25 Flk-1+ cells were plated
at different densities into cardiac MEC and
grown for 6 days. At day 6, the colonies
were counted and replated in liquid culture
for an additional 3–5 days. The percentage of contracting cardiac colonies was multiplied by the number of colonies from D6 to determine
the number of cardiac colonies. Bars represent standard error of the mean.
(C) BL-CFC and CV-CFC potential of the indicated day 3.25 and 4.25 populations. Blast colonies were scored following 4 days of growth, whereas
the cardiac colonies were counted at day 6. Forty-eight cardiac colonies were picked in each of six experiments and plated into liquid culture.
The proportion of expanded colonies per 2 3 104 cells that generated contracting cells was scored 3–5 days later. The number of cardiac col-
onies was determined by multiplying the proportion of colonies that generated contracting cells by the number of colonies scored in the MEC
culture. Bars represent standard error of the mean number of colonies from six cultures.maturation to a population consistent with primary heart
field myocytes. One Tbx5+ colony at this stage faintly
coexpressed Isl1. All Nkx2.5+ 6-day-old colonies
expressed MLC-2a, and four of six expressed Tbx5.
Only one colony expressed Isl1, and most showed re-
duced levels of the endothelial genes Flk-1 and Flt-1.
Collectively, these expression patterns support the
interpretation that the compact colonies contain popu-
lations of cardiomyocytes and endothelial cells. The ex-
pression patterns of Isl1 and Tbx5 suggest that colonies
representing both primary and secondary heart field
populations develop early in the cultures. The loss of
Isl1-expressing colonies and the increase in Tbx5-
expressing colonies may imply that the conditions in
the cardiac MEC assay do not support the growth and
maturation of those containing secondary heart field
cells.
To further evaluate their lineage potential, individual
4-day-old colonies were picked and expanded on fibro-
nectin-coated microtiter wells in SF medium supple-
mented with BMP4, Dkk1, VEGF, bFGF, D4T, and FCS.
After 2–3 days of culture, 30% of colonies gave rise to
detectable contracting cells. Immunofluorescence anal-
ysis of expanded populations from individual colonies
showed the presence of cells that expressed the
endothelial marker CD31 in the majority (39 of 46) of col-
onies that expressed the cardiomyocyte marker cTnT
(Figure 3C). Molecular analyses of the expanded con-
tracting cardiac colonies demonstrate the expression
of genes indicative of the endothelial (Flk-1, VECAD,
CD31), VSM (smooth muscle actin [SMA] and Calponin),
and cardiomyocyte (Nkx2.5, GATA-4, Tbx5, Tbx20,
MLC-2a) (Figure 4A, bulk) lineages. Consistent with the
later stage methylcellulose colonies, Isl1 was not
expressed in any of the expanded populations. Of 18
expanded colonies analyzed, all expressed Tbx5, and
none expressed Isl1. In addition to these genes,neuregulin (Nrg1) a gene expressed in endocardial cells
(Meyer and Birchmeier, 1995; Meyer et al., 1997), was
also detected, suggesting the presence of endocar-
dium. Gata-1, a hematopoietic-specific gene, and Myo-
genin and MyoD genes associated with skeletal muscle
were not expressed in these cultures. BL-CFC-derived
blast colonies expressed Gata-1 and the endothelial
genes, but not the genes associated with cardiac devel-
opment (Figure 4A, blast).
The above replating studies demonstrate that progen-
itors with cardiomyocyte, endothelial, and VSM lineage
potential are contained within individual D4.25 Flk-1+-
derived cardiac colonies and support the notion that
these populations share a common ancestor, provided
that the colonies are clonal. As a first approach to ad-
dress the issue of clonality, the relationship between
the number of D4.25 Flk-1+ plated cells and the number
of cardiac colonies formed was determined. As shown in
Figure 4B, this relationship is linear with a slope of one,
suggesting that the cardiac colonies are derived from
a single-colony-forming unit and not a result of aggrega-
tion. As a second method to establish the clonality of the
cardiac colonies, single D4.25 Flk-1+ cells were depos-
ited into microtiter wells containing cardiac MEC. In
seven separate experiments, cardiac colonies devel-
oped at a frequency of 30–48 per 480 cells plated. Anal-
ysis of the expanded populations from these colonies in-
dicated that they expressed the same spectrum of
cardiac, endothelial, and VSM genes found in the cells
generated from cardiac colonies from the bulk cultures
(Figure 4A, single-cell derived). Colonies generated
from single cells also gave rise to contracting cardio-
myocytes when cultured in cardiac MEC for 6 days.
The results from these analyses indicate that the D4.25
Flk-1+ population contains multipotential progenitors
that have the ability to generate colonies containing
cells of the cardiac, endothelial, and VSM lineages.
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CFCs in the Early Embryo
(A) Early and late PS embryos were dissected
into proximal and distal sections. Neural-
plate and head-fold embryos were dissected
into anterior and posterior sections. The YS
was removed from all embryos. Embryo frag-
ments were dispersed into a single-cell sus-
pension and assayed for CV-CFC potential
in cardiac MEC.
(B) Six-day-old colonies (cardiac colony)
were picked and expanded in liquid culture
for 5 days (contracting cardiac colony). The
arrow indicates area of contracting cells
(see Supplemental Data and Movie S3).
(C) PCR analysis of expanded embryo-
derived cardiac colonies picked from bulk
cultures of anterior embryo cells (anterior
head fold [HF]) or from microtiter wells
seeded with single Flk-1+ cells (single-cell
Flk-1+) isolated from entire head-fold-stage
embryos. Colonies were picked at day 4 of
growth in the MEC cultures and expanded
for an additional 3 days in liquid culture prior
to molecular analysis. Lanes represent indi-
vidual colonies. Controls are the same as for
Figure 4A.Hereafter, these progenitors will be referred to as
cardiovascular-colony-forming cells (CV-CFCs).
Analysis of the different GFP-Bry/Flk-1 fractions for
hemangioblast and cardiovascular progenitor potential
revealed that the majority of BL-CFC potential was found
in the D3.25 Flk-1+ population, whereas the CV-CFCs
segregated to the D4.25 Flk-1+ fraction (Figure 4C). The
lack of CV-CFC potential in the D3.25 Flk-12 population
from which the D4.25 Flk-1+ population arises suggests
that these progenitors represent a specific stage of mat-
uration during cardiac mesoderm development. These
findings demonstrate that the BL-CFC and the CV-CFC
represent distinct progenitors and that the hemangio-
blast and cardiac lineages are generated within Flk-1+
populations that develop in a defined temporal pattern
of differentiation.
Multipotential Cardiovascular-Colony-Forming Cells
Can Be Isolated from the Head-Fold-Stage Embryo
To determine if the early embryo contains progenitors
similar to the CV-CFCs, we isolated various regions
from different staged embryos and cultured the cells
in cardiac MEC. For these analyses, we assayed the
proximal/distal regions of the PS from midstreak and
late-streak embryos and the anterior/posterior region
containing the heart primordium of neural plate and
head-fold embryos (Tam et al., 1997) (Figure 5A). The
yolk sac (YS) was removed from all embryos prior to dis-
section. Cardiac colonies, similar to those obtained in
the ES-cell system, able to differentiate into contracting
cells were obtained only from the anterior region of the
neural plate and head-fold-stage embryos (Figure 5B,
Supplemental Data, and Movie S3). The anterior neural
plate embryos gave rise to 0–1 contracting colonies per
embryonic section of 13 embryos analyzed. The laterstage head-fold embryos contained 1–8 colonies per
equivalent region of 50 embryos analyzed. No colonies
were generated from PS embryos (40 total embryos) or
from the posterior sections of neural-plate and head-
fold-stage embryos.
When 4-day-old embryo-derived colonies were
picked and expanded in liquid culture for 3 days, 3 out
of 29 generated contracting cells. Molecular analysis
of these colonies revealed expression of cardiac-, endo-
thelial-, and VSM-associated genes, in a pattern similar
to that observed for the cells derived from the CV-CFC.
(Figure 5C, anterior head fold). To determine if the em-
bryo-derived colonies represent clones, single Flk-1+
cells from head-fold-stage embryos were deposited
into microtiter wells containing cardiac MEC. In two sep-
arate experiments, 33 and 31 cardiac colonies were
detected from 830 cells plated. After expansion, a repre-
sentative analysis of the cells generated from these col-
onies revealed the expression of endothelium-, VSM-,
and cardiac-associated genes (Figure 5C, single-cell
Flk-1+). Isl1 was expressed in two of ten colonies ana-
lyzed, whereas Tbx5 was detected in one, suggesting
that both heart fields are represented. Of a total of 21
bulk- and clonal-embryo-derived colonies analyzed, 11
expressed Tbx5, while 2 expressed Isl1. In all, the find-
ings from these analyses demonstrate the existence of
Flk-1+ multipotential cardiovascular progenitors in the
region of head-fold-stage embryos that will give rise to
the heart.
Discussion
The identification of a Flk-1+ cardiovascular progenitor
in this study is consistent with observations from in
vivo lineage-tracing studies and expression analysis
Flk-1 Cardiovascular Progenitor Cells
729Figure 6. Model of Mesodermal Specification
to the Hematopoietic and Vascular Lineages
of the YS Blood Islands and to the Developing
Heart
In the ES-cell differentiation system (ES/EB)
and the developing embryo (epiblast) the
Bry+/Flk-1+ BL-CFC develops first to gener-
ate the hematopoietic and vascular lineages
of the blood islands, and this is followed by
the development of the Bry+/Flk-1+ CV-CFC
to establish the myocardial and endothelial
lineages of the heart.that demonstrate Flk-1 expression early in cells of the
cardiac crescent and later in the endocardium and myo-
cardium (Ema et al., 2006; Motoike et al., 2003). Of signif-
icance in the most recent of these studies was the find-
ing that Flk-1 was not expressed in cells of the PS but
was upregulated as they exited the streak (Ema et al.,
2006). The progression of the D3.25 GFP-Bry+/Flk-12
cells to the D4.25 Flk-1+ population defined here may
be representative of the onset of Flk-1 expression in
the cardiogenic population as the cells exit the PS in
vivo. The presence of the CV-CFC in the D4.25 but not
in the D3.25 population and in the anterior region of
the mouse but not in the PS suggests that this progeni-
tor represents a specific stage of cardiovascular devel-
opment and not an uncommitted mesoderm cell. The
fact that it responds to molecules found in the heart field
of the embryo to generate distinct colonies in MEC cul-
tures further supports the interpretation that it represent
a normal stage of development.
In a previous study, Yamashita et al. demonstrated
that cardiomyocytes could be generated from Flk-1+
progenitors isolated from ES-cell differentiation cultures
and early embryos (Yamashita et al., 2005). Our current
study extends these findings in several important
ways. First, based on temporal patterns of development,
we have identified the cardiogenic Flk-1+ population as
distinct from the Flk-1 population that gives rise to the
hemangioblast. Of significance is the finding that the se-
quential development of the hemangioblast and cardiac
Flk-1 populations in the ES-cell model recapitulates
the temporal development of the hemangioblast and car-
diac lineages in vivo (Kinder et al., 1999). The identifica-
tion of this cardiogenic Flk-1 population enables the rou-
tine generation of populations with an unprecedented
high frequency of cardiomyocytes (>50%). Second, our
molecular analyses revealed that specification of the
cardiogenic Flk-1 population precedes the onset of ex-
pression of transcription-factor genes associated with
the earliest stage of cardiac induction. Third, we have
shown that the cardiogenic Flk-1+ population contains
a progenitor that we have named the CV-CFC that will
grow in methylcellulose and generate distinct colonies
that display both cardiac and vascular potential. The de-
velopment of the cardiac colonies provides a new quan-
titative assay for cardiovascular progenitors. Fourth, our
study has demonstrated the existence of comparableCV-CFCs that develop in the anterior region of the
head-fold-stage embryos. The CV-CFC identified in this
study can be considered the cardiovascular equivalent
of the hemangioblast of the hematopoietic system and
represents one of the earliest stages of cardiac develop-
ment described to date.
The identification of the CV-CFC in both the ES-cell
differentiation model as well as in the early embryo
adds strong support to the notion that the cardiac line-
ages develop from a progenitor with endothelial poten-
tial (Lee et al., 1994; Linask and Lash, 1993). The pres-
ence of a common progenitor for myocardium and
endocardium is supported by studies in the zebrafish
that demonstrate that single cells in the ventral marginal
zone have the potential to generate both lineages (Lee
et al., 1994). The observation that the chick cell line
QCE-1 can be induced to both endothelial and myocar-
dial lineages is also consistent with the notion of a com-
mon progenitor for both lineages (Eisenberg and Bader,
1995). Analyses of cardiac development in the chick em-
bryo, however, have failed to identify a common progen-
itor in the early embryo (Cohen-Gould and Mikawa,
1996). This discrepancy may reflect the fact that the in-
vestigators analyzed a later stage of development than
we have done in this study.
Segregation of two distinct progenitors with endothe-
lial potential, the BL-CFC and the CV-CFC, to different
Flk-1 populations that appear in a sequential fashion is
not only consistent with the temporal development of
the hemangioblast and cardiac lineages in vivo but
also raises the intriguing possibility that the types of en-
dothelial cells generated by them may differ. Expression
of the endocardial gene neuregulin in the cardiac but not
in the blast colonies is consistent with this interpretation
and suggests that at least some of the vascular potential
of the cardiac colonies could represent endocardium
(Meyer and Birchmeier, 1995; Meyer et al., 1997). To-
gether, these observations support a model in which
the BL-CFC develops first to generate the hematopoi-
etic and vascular components of the blood islands
(Huber et al., 2004), and the CV-CFC develops next to
establish the myocardial and endocardial lineages of
the heart (Figure 6, model). The notion that the myocar-
dial and early endothelial heart lineages develop from a
common progenitor could account for their close prox-
imity and cooperative effects during heart development.
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pressed in endocardium, while its receptors ErbB2 and
ErbB4 are expressed in the underlying myocardium.
Paracrine secretion of neuregulin-1 from the endocar-
dium has been found to be sufficient for induction of
the cardiac conduction system from myocardium (Rent-
schler et al., 2002). Similarly, cooperative interactions
between these cell types have been demonstrated for
trabeculation (Gassmann et al., 1995; Lee et al., 1995)
and myocyte growth and survival (Lavine et al., 2005;
Zhao et al., 1998). Access to the CV-CFC and cardiac
colonies provides a powerful model for further investi-
gating interactions between these different populations
at a clonal level.
The existence of two distinct heart fields that develop
sequentially and express unique molecular profiles has
been described by a number of groups (Cai et al.,
2003; Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo
et al., 2001; Zaffran et al., 2004). While it is difficult to un-
equivocally define a lineage based on the expression
patterns of several genes, our findings do suggest that
both the primary and secondary heart fields are repre-
sented in the colony assay. In addition, the expression
of vascular genes in ES-cell-derived Isl1+Tbx52 and
Isl1-Tbx5+ colonies (Figure 3B) as well as in expanded
populations from those grown from the embryo
(Figure 5C) suggests that both heart fields develop
from progenitors with vascular potential. To date, our
analyses have identified only one colony that may ex-
press markers of both primary and secondary lineages.
Identification of colonies that express markers of both
lineages is expected to be rare, as Meihlac et al. have
provided evidence that these lineages segregate at
much earlier stages during gastrulation (Meilhac et al.,
2004). Our analysis of different aged colonies and of ex-
panded outgrowths from the colonies indicates a loss of
Isl1 with concomitant gain of Tbx5 expression with time.
If these patterns are indicative of the presence of sec-
ondary and primary heart-field populations, respec-
tively, these findings would suggest that our culture
conditions favor the growth of the primary heart field
cells. In the embryo, the secondary heart field develops
both anterior and dorsally to the cardiac crescent, posi-
tioning it closer to the signals derived from the neural
tube. These observations suggest that progenitors of
the secondary heart field may develop in a cytokine en-
vironment different from those of primary heart field. The
combination of cytokines in our cardiac MEC assay may
be more representative of the environment of the pri-
mary heart field. The availability of a clonogenic assay
for cardiac progenitors provides a unique opportunity
to investigate the signaling pathways that regulate the
development of these distinct cardiogenic lineages.
In summary, the findings reported here have identified
and characterized a Flk-1+ multipotential cardiovascular
progenitor in the ES-cell differentiation culture as well as
in the early embryo. The identification of this progenitor
provides a novel cell population for studies aimed at
uncovering the mechanisms of diversification of these
lineages and the establishment of the cardiovascular
system. In addition to providing novel cell types for
developmental studies, the D4.25 Flk-1+ population en-
riched for CV-CFC is an ideal population for transplanta-
tion for the treatment of cardiovascular disease. Giventhe fact that the CV-CFC represents a progenitor with
both cardiac and vascular potential, one might expect
significant regeneration of both the vasculature and
myocardium following transplantation to the damaged
heart.
Experimental Procedures
ES Cell Growth and Differentiation
ES cells were cultured and differentiated as previously described
(Fehling et al., 2003). For reaggregation, 5 3 105 sorted cells were
reaggregated in 500 ul StemPro-34 SF medium (GIBCO), 2 mM L-
glutamine, transferrin (200 ug/ml), 0.5 mM ascorbic acid (Sigma),
4.53 1024 M MTG, human (h) VEGF (5 ng/ml) (R&D Systems), hbFGF
(30 ng/ml) (R&D Systems) per well in 24-well low-cluster plates
(Costar). For direct plating of populations, 63 104 cells were seeded
onto individual wells of a 96-well flat bottom plate (Becton Dicken-
son, Franklin Lakes, NJ) coated with gelatin in StemPro-34 SF
medium, 2 mM L-glutamine, hVEGF (5 ng/ml), and hbFGF (30 ng/ml).
Flow Cytometry
EBs were harvested and trypsinized, and single-cell suspensions
were analyzed on an LSR flow cytometer (Becton Dickinson) or
sorted on either a Moflow cell sorter (Cytomation, Ft. Collins, CO)
or Vantage cell sorter (Becton Dickinson). Cells were incubated
with mAb in IMDM/10% FCS. Stains included biotinylated Flk-1
mAb, revealed with streptavidin PE-Cy5 (BD Pharmingen) and,
with or without, PE-conjugated anti-CD117 (BD Pharmingen), of
which the highest 3%–5% was excluded during the D3.25 sorts.
Anti-cardiac isoform of TroponinT (cTnT) (NeoMarkers, Fremont,
CA) revealed with Cy3-conjugated donkey anti-mouse IgG (Jackson
ImmunoResearch) staining was performed on cells fixed with 4%
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in
PBS. Staining was done in the presence of 0.5% Saponin (Sigma).
Colony Assays
Blast cell colonies were generated as previously described (Choi
et al., 1998). For the generation of cardiovascular cell colonies
(CV-CFC assay), EB and embryonic cells were plated in the same
conditions of the BL-CFC assay minus mIL-6 and with the addition
of hVEGF (5 ng/ml), hbFGF (30 ng/ml), hBMP4 (50 ng/ml) (R&D Sys-
tems), hDKK (150 ng/ml) (R&D Systems). For CV-CFC frequency
analysis, colonies were counted after 6 days of culture, and a repre-
sentative number were deposited into a gelatinized 96-well micro-
titer plate in StemPro 34 media as above. Contracting cardiac colo-
nies were scored after an additional 5 days. For CV-CFC molecular
analysis, cardiac colonies were isolated after 4 days and deposited
into fibronectin coated 96-well microtiter plates with StemPro 34,
25% D4T endothelial-cell-conditioned medium, 2% FCS, 2 mM L-
glutamine, hVEGF (5 ng/ml), hbFGF (30 ng/ml), hBMP4 (50 ng/ml),
and hDKK (150 ng/ml).
Molecular Analysis
The preparation of 30 cDNA was performed as previously described
(Brady and Iscove, 1993; Robertson et al., 2000). 30 cDNA was di-
luted and underwent gene-specific PCR by using primers designed
within the most 30 400 bp, including the UTR (Figure S1). PCR condi-
tions were: 94C, 5 min followed by X cycles (94C, 30 s; 55C, 30 s;
72C, 30 s); 72C, 10 min.
Immunohistochemical Staining
Colonies were fixed in the 96-well microtiter plate with 4% parafor-
maldehyde for 30 min, washed, and stained with rat anti-mouse
CD31 revealed with Cy2-conjugated donkey anti-rat IgG (Jackson
ImmunoResearch). Cells were permeablized with PBS/0.1% Tween-
20, washed, and stained in PBS/10% FCS for cTnT revealed with
Cy3-conjugated donkey anti-mouse IgG. Bright-field and fluores-
cent images were acquired on a Leica DMIRB inverted fluorescent
microscope with MagnaFire software (Optronics, Goleta, CA).
Dissection and Culture of Embryos
Male mice heterozygous for GFP knockin of the Brachyury locus
(GFP-Bry+/2) were mated with Swiss Webster female mice to
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731generate mid- and late-PS embryos, isolated at E7.0, or neural-plate
and head-fold embryos, isolated at E7.5. Embryos were removed
from decidua and Reicher’s membrane and dissected in IMDM con-
taining 15% FCS. Dissections were done under a Leica MZFLIII fluo-
rescence dissecting stereomicroscope with tungsten needles (Fine
Science Tools). Embryo fragments were dispersed into a single-
cell suspension by incubation in a 2.5% trypsin-EDTA solution
(Sigma) for 5 min at 37C and by vortexing. 20,000–13 105 dispersed
cells from each fragment were added to 1 ml of Cardiac-MEC, incu-
bated in 5% oxygen for 6 days, and then counted. A representative
number of colonies from each population were picked and replated
onto gelatin-coated microtiter wells containing cardiac expansion
medium. After an additional 4–6 days, contracting cardiac colonies
were counted. Alternatively, for clonal analysis, head-fold embryos
were dispersed into a single-cell suspension stained for Flk-1 and in-
dividually deposited into cardiac MEC. After 4 days, colonies were
picked and expanded for molecular analysis.
Animal Care and Use
All experiments conducted on animals were performed in accor-
dance with institutional guidelines and regulations. These experi-
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tional Animal Care and Use Committee review board.
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Supplemental Data include a figure and three movies and are avail-
able at http://www.developmentalcell.com/cgi/content/full/11/5/
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